High mobility group box 1 pseudogene 16 (HMGB1P16)

High mobility group box 1 pseudogene 16 (HMGB1P16) is a human genomic locus classified as a pseudogene, meaning it is a DNA segment that closely resembles the functional HMGB1 gene but is disrupted by mutations that prevent production of a functional protein[1][3][5]. Pseudogenes result from evolutionary gene duplication events and generally lack biological activity, regulatory function, or protein expression. Although some pseudogenes can occasionally exert regulatory effects at the RNA level or act as decoys in gene regulation, as reported broadly for certain pseudogenes[2][4], no specific regulatory or functional role has been assigned to HMGB1P16 in the current biomedical literature or genomic databases. Therapeutic interest, disease roles, and drug interactions attributed to HMGB1 do not apply to HMGB1P16. HMGB1P16 should not be confused with high mobility group box 1 (HMGB1), the parent gene/protein, which is a well-established therapeutic target involved in inflammation, cancer, and numerous molecular pathways. HMGB1P16 encodes no functional product and is not a target for pharmacological intervention[1][3][5].

Other names

high-mobility group box 1 pseudogene 16

No mechanisms of action for drugs targeting this molecule exist since it does not encode a protein or directly mediate biological functions